Positron (POSC) Stock Price, News & Analysis

Company Overview

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.

Key Stats

• Today's Range: $1.45 to $1.65
• 50-Day Range: $1.35 to $1.90
• 52-Week Range: $0.88 to $2.94
• Volume: 3,435 shs
• Average Volume: 23,099 shs
• Market Capitalization: $45.39 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

POSC Stock Analysis - Frequently Asked Questions

How have POSC shares performed this year?

Positron's stock was trading at $1.01 at the start of the year. Since then, POSC shares have increased by 43.6% and is now trading at $1.45.
View the best growth stocks for 2025 here.

How do I buy shares of Positron?

Shares of POSC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Positron own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Positron investors own include Rocket Lab USA (RKLB), Atlas Lithium (ATLX), Archer Aviation (ACHR), Camber Energy (CEI), OriginClear (OCLN), Baltic International USA (BISA) and

Company Calendar

• Today: 5/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:POSC
• CIK: N/A
• Web: www.positron.com
• Phone: (317) 576-0183
• Fax: 630-537-1249
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.08)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-1,640,000.00
• Net Margins: -278.51%
• Pretax Margin: -278.51%
• Return on Equity: N/A
• Return on Assets: -88.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.62
• Quick Ratio: 0.12

Sales & Book Value

• Annual Sales: $740,000.00
• Price / Sales: 61.34
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.04) per share
• Price / Book: -36.25

Miscellaneous

• Outstanding Shares: 31,305,000
• Free Float: 22,609,000
• Market Cap: $45.39 million
• Optionable: Not Optionable
• Beta: 0.44